|
Scritto da CDRH New
|
 The FDA is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. ... ...
|
|
Scritto da CDRH New
|
 The FDA is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. ... ...
|
|
Scritto da CDRH New
|
 The topic to be discussed relates to imaging of the posterior segment of the eye (e.g. retinal nerve fiber layer, optic nerve head, ganglion cell layer) using Optical Coherence Tomography (OCT, time-domain and spectral-domain), with particular emphas ... ...
|
Restylane-L is a transparent hyaluronic acid gel that is injected into a patient?s lips to increase their size. Restylane-L is also approved for injection into facial tissue to smooth wrinkles and folds, especially around the nose and mouth... ... ...
Meeting materials posted for Sept. 21, 2012 Orthopaedic and Rehabilitation Devices Panel Meeting ... ...
The FDA is extending the comment period pertaining to information collection issues under the Paperwork Reduction Act of 1995 (the PRA) associated with the proposed rule, Unique Device Identification System, that appeared in the Federal Register... ... ...
Premarket Approval (PMA) Summary Review Memos for 180-Day Design Changes (P910023/S295 and P030054/S223) ... ...